| Loss per common share |
Loss) per common share
All shares issuable for both periods were anti-dilutive because of the reported net loss. Basic and diluted loss per share for the three months ended September 30, 2016 and 2015, and nine months ended September 30, 2016 and 2015, respectively, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, |
|
Nine months ended September 30, |
|
|
2016 |
|
2015 |
|
2016 |
|
2015 |
Net income (loss) attributable to stockholders |
|
$ |
207,868 |
|
|
$ |
(948,842 |
) |
|
$ |
(1,100,839 |
) |
|
$ |
(1,929,144 |
) |
Weighted average shares outstanding - Basic |
|
19,640,812 |
|
|
17,153,999 |
|
|
19,071,497 |
|
|
16,575,879 |
|
Basic income (loss) per share |
|
$ |
0.01 |
|
|
$ |
(0.06 |
) |
|
$ |
(0.06 |
) |
|
$ |
(0.12 |
) |
Weighted average shares outstanding - Diluted |
|
20,229,120 |
|
|
17,153,999 |
|
|
19,071,497 |
|
|
16,575,879 |
|
Diluted income (loss) per share |
|
$ |
0.01 |
|
|
$ |
(0.06 |
) |
|
$ |
(0.06 |
) |
|
$ |
(0.12 |
) |
Anti-dilutive shares underlying stock options outstanding |
|
|
|
|
1,186,325 |
|
|
1,130,158 |
|
|
1,186,325 |
|
Anti-dilutive convertible debentures |
|
|
|
|
625,000 |
|
|
889,830 |
|
|
625,000 |
|
Anti-dilutive warrants outstanding |
|
|
|
|
— |
|
|
250,000 |
|
|
— |
|
|